Tickerplace logo

Tickerplace

Drugs Made In America Acquisition Corp. Ordinary Shares logo

DMAADrugs Made In America Acquisition Corp. Ordinary Shares

DMAA Stock Price, Valuation & Chart | Drugs Made In America Acquisition Corp. Ordinary Shares

Compare
$10.760+0.01 (+0.05%)

At close · 02 Sept 2026, 08:00 pm

Sector: Financial ServicesIndustry: Shell CompaniesDMAA intrinsic valueDMAA calculated fair value vs price
OverviewFinancialsDividendsRatios

DMAA Historical price chart

DMAA Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization261.22M
PE Ratio53.8
EPS0.2
Trading Volume18.22K
Today's High/Low10.77/10.75
Dividend Yield0.00
52 Week High/Low10.77/10.23
Shares Outstanding24.28M
DMAA Financial Statement
DMAA Analyst ratings
DMAA Analysis & performance metrics

DMAA Company profile

Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock…

DMAA Management team

Management
Glenn Charles WormanCFO
Chief Financial Officer
Lynn StockwellCEO
Chief Executive Officer & Executive Chairman
Total 2 executives

DMAA Frequently asked questions

What is Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Stock Price?

Current stock price of Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) stock is $10.760. The stock price is +0.05% higher in the session. The intraday range can be seen from this page. Volume of Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) stock is 18.22K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) stock price going up or down today?

The stock price of Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) can change with earnings, company news, and overall market sentiment. Drugs Made In America Acquisition Corp. Ordinary Shares operates in the Financial Services / Shell Companies market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Drugs Made In America Acquisition Corp. Ordinary Shares stock expensive at its current price?

Whether Drugs Made In America Acquisition Corp. Ordinary Shares looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for DMAA on this page is 53.80. EPS on this page is 0.20. Compare those figures with peers and growth expectations before deciding if the current Drugs Made In America Acquisition Corp. Ordinary Shares price is justified.

How has the stock price of Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) performed historically?

Historical performance for Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how DMAA reacted to past earnings and market events.

Should I buy Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) stock, at this price?

Buying Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) depends on your risk tolerance, time horizon, and portfolio needs. As a Financial Services name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.